The global veterinary therapeutics market was valued at US$ 25,974.2 Mn in 2016 and is projected to increase significantly at a CAGR of 6.0% from 2017 to 2026. The first five-year cumulative revenue (2017-2021) is projected to be US$ 154,050.2 Mn, which is expected to increase rather significantly over the latter part of the five-year forecast period.
Global Veterinary Therapeutics Market: Segmental Snapshot
By type: Therapeutic drugs segment is estimated to register a CAGR of over 6.2%, thereby accounting for highest revenue share in the application segment.
By end-user: Hospitals segment is estimated to account for highest revenue share among the product type segments, registering a CAGR of over 6.3% over the forecast period.
By region: The market in North America accounted for highest revenue share in the global veterinary therapeutics market in 2016, and is expected to record highest CAGR of over 5.9% between 2017 and 2026.
↧
Worldwide Veterinary Therapeutics Market about to hit CAGR of 6.0% from 2017 to 2026
↧